Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Purine nucleoside phosphorylase targeted by annexin v to breast cancer vasculature for enzyme prodrug therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Purine nucleoside phosphorylase targeted by annexin v to breast cancer vasculature for enzyme prodrug therapy.
Purine nucleoside phosphorylase targeted by annexin v to breast cancer vasculature for enzyme prodrug therapy. PLoS One. 2013; 8(10):e76403.
View in:
PubMed
subject areas
Annexin A5
Annexin A5
Antineoplastic Agents
Antineoplastic Agents
Breast Neoplasms
Breast Neoplasms
Cell Line, Tumor
Cell Line, Tumor
Cell Membrane
Cell Membrane
Female
Female
Humans
Humans
Kinetics
Kinetics
Models, Molecular
Models, Molecular
Molecular Targeted Therapy
Molecular Targeted Therapy
Neovascularization, Pathologic
Neovascularization, Pathologic
Prodrugs
Prodrugs
Protein Binding
Protein Binding
Protein Conformation
Protein Conformation
Protein Stability
Protein Stability
Purine-Nucleoside Phosphorylase
Purine-Nucleoside Phosphorylase
Recombinant Fusion Proteins
Recombinant Fusion Proteins
authors with profiles
Roger G Harrison